Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits in the top decile of US sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count).

305 total trials 24 currently recruiting 252 completed early-phase tilt top decile by trial count

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): 305 sponsored US clinical trials, 24 recruiting.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sponsors 305 registered US clinical trials on ClinicalTrials.gov, 24 of them currently recruiting, and 252 completed. 35 of these trials are in Phase 3-4 (later-stage) and 89 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pregnancy, with 8 trials.

Top-decile sponsor footprint

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) ranks in the top decile of sponsors by registered trial count (#116 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 66/100

252 of 279 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

305 total, page 3 of 7

COMPLETED Phase 2

Preventing Excessive Weight Gain in Adolescent Girls at High-Risk for Adult Obesity

NCT00680979

COMPLETED NA

FES Assisted Cycling in Children With CP

NCT04688424

COMPLETED Phase 4

Morphine PK Subgroup Analysis

NCT01322191

COMPLETED

Eating Behavior in Adolescents

NCT00631644

COMPLETED

Lifestyle and Fertility Study on Antioxidant Status, Diet and Early Pregnancy

NCT00642590

COMPLETED

Streptococcal Infection and Respiratory Distress in Newborns

NCT00612937

COMPLETED Phase 2

Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)

NCT00621478

TERMINATED Phase 1

Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones

NCT00556400

COMPLETED

Infant Immune Response to Bacterial Infection

NCT00546195

COMPLETED

Calibrating Imaging Techniques to Study Blood Flow

NCT00546091

COMPLETED

Tobacco Smoke and Lead Exposure During Pregnancy

NCT00514280

TERMINATED

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

NCT00504218

TERMINATED Phase 3

Study of Citicoline for the Treatment of Traumatic Brain Injury (COBRIT)

NCT00545662

COMPLETED NA

The Effects of Aspirin in Gestation and Reproduction

NCT00467363

COMPLETED Phase 1

Effects of Betahistine Hydrochloride in Overweight Women

NCT00459992

COMPLETED NA

Healthy Lifestyles for People With Intellectual Disabilities

NCT00597948

COMPLETED

A Study of the Pharmacology of Tamiflu in Pregnancy

NCT01203527

COMPLETED Phase 1

Classification-Directed Treatment of Low Back Pain

NCT00802724

COMPLETED NA

The Healthy Families Project

NCT01193374

COMPLETED Phase 2

Lithium for the Treatment of Pediatric Mania

NCT00442039

COMPLETED

Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age

NCT00386789

COMPLETED NA

Prevention of Vitamin D Deficiency

NCT00494104

TERMINATED

Endocrine and Psychological Evaluation of Adopted Children

NCT00368043

COMPLETED

Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome

NCT00559390

COMPLETED Phase 4

Lopinavir/Ritonavir (Kaletra) PK in Children

NCT00810108

TERMINATED Phase 3

Refractory Urge Incontinence and Botox Injections

NCT00373789

TERMINATED Phase 1

Micafungin Lock Therapy

NCT00809887

COMPLETED Phase 2

Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)

NCT00332033

COMPLETED Phase 1

Non-Exercise Activity Thermogenesis (NEAT) in Children

NCT00315172

COMPLETED

Insulin Resistance and Breast Cancer

NCT00304941

COMPLETED

Exercise in Insulin-Resistant Minority Adolescents

NCT00345436

COMPLETED

Effects of Endometriosis on Bone Mineral Density

NCT00291278

COMPLETED Phase 3

Building Futures for Youth - Phase III

NCT00341471

COMPLETED Phase 1

Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine

NCT00277147

COMPLETED Phase 2

Family Management of Type 1 Diabetes in Children

NCT00273286

COMPLETED

Body Heat Content and Dissipation in Obese and Normal Weight Adults

NCT00266500

COMPLETED Phase 1

Pilot Program for Targeted Prevention of Child or Adolescent Weight Gain

NCT00263536

COMPLETED

Health Behaviors in School-age Children: A World Health Organization Cross-National Study

NCT00341510

COMPLETED Phase 1

An Open Label Evaluation of the Pharmacokinetics and Safety of Single Dose Intravenous Azithromycin in Preterm Neonates

NCT00760279

COMPLETED Phase 2

Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers

NCT00341432

COMPLETED

Media-Smart Youth Program Evaluation Study

NCT00340795

COMPLETED Phase 2

Prevention of Environmental Tobacco Smoke Exposure in Children 0-12 Months Old

NCT00340106

COMPLETED

Hypertonia in Patients With Cerebral Palsy

NCT00123708

TERMINATED Phase 2

Use of Rosiglitazone in the Treatment of Endometriosis

NCT00115661

COMPLETED Phase 2

Short-term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome

NCT00114634

COMPLETED Phase 1

Lorazepam for the Treatment of Status Epilepticus in Children

NCT00114569

TERMINATED Phase 3

A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy

NCT00545597

COMPLETED

Family Study on Preeclampsia

NCT00344162

COMPLETED Phase 2

Role of Nutrition and Hormones in Boys With Disordered Growth

NCT00102258

COMPLETED Phase 2

Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies

NCT00342706

← Previous Page 3 of 7 Next →

Phase Distribution

PhaseTrial count
Phase 1 40
Phase 2 49
Phase 3 23
Phase 4 12

What is open in the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline

24 recruiting of 305 indexed (8% open); 252 completed (83%).

Phase mix: 35 late (III/IV) vs 89 early (I/II) (early-phase heavy).

Top condition: Pregnancy (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): open-pipeline peers nationwide

Peers matched on 305 registered trials and 8% open enrollment, not the therapeutic-area sidebar.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 0%5%10%15% Total trials Recruiting share Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)CelgeneAllerganKaiser PermanenteUniversity of ArkansasBoston Scientific CorporationNovo Nordisk A/SHoffmann-La RocheUnited Therapeutics
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 305 trials (± recruiting share)

Sponsors near 8% open enrollment (± trial volume)

What to do with this Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) page

305 registered trials is a research-attention snapshot, not an endorsement of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) or any single study.

  • 24 of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Pregnancy is the condition Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pregnancy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) pipeline card: 305 registered trials from official public datasets.Report a data error.